featured
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing–Remitting MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Neurology 2022 Aug 17;[EPub Ahead of Print], I Roos, C Malpas, E Leray, R Casey, D Horakova, EK Havrdova, M Debouverie, F Patti, J De Seze, G Izquierdo, S Eichau, G Edan, A Prat, M Girard, S Ozakbas, P Grammond, H Zephir, J Ciron, E Maillart, T Moreau, MP Amato, P Labauge, R Alroughani, K Buzzard, O Skibina, M Terzi, DA Laplaud, E Berger, F Grand'Maison, C Lebrun-Frenay, E Cartechini, C Boz, J Lechner-Scott, P Clavelou, B Stankoff, J Prevost, L Kappos, J Pelletier, V Shaygannejad, BI Yamout, SJ Khoury, O Gerlach, DLA Spitaleri, V Van Pesch, O Gout, R Turkoglu, O Heinzlef, E Thouvenot, PA McCombe, A Soysal, B Bourre, M Slee, T Castillo-Trivino, S Bakchine, R Ampapa, EG Butler, A Wahab, RA Macdonell, E Aguera-Morales, P Cabre, NH Ben, A Van der Walt, G Laureys, L Van Hijfte, CM Ramo-Tello, N Maubeuge, S Hodgkinson, JL Sánchez-Menoyo, MH Barnett, C Labeyrie, S Vucic, Y Sidhom, R Gouider, T Csepany, J Sotoca, K de Gans, A Al-Asmi, YD Fragoso, S Vukusic, H Butzkueven, T KalincikFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.